Mechanism of action and clinical impact of ribociclib — Response

Debu Tripathy; Aditya Bardia; William R. Sellers

doi:10.1158/1078-0432.CCR-17-1819

Mechanism of action and clinical impact of ribociclib — Response

Debu Tripathy, Aditya Bardia, William R. Sellers

Breast Medical Oncology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	5658
Number of pages	1
Journal	Clinical Cancer Research
Volume	23
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-17-1819
State	Published - Sep 15 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-17-1819

Cite this

@article{a5a2f21254cd47e2a15b68980af3f133,

title = "Mechanism of action and clinical impact of ribociclib — Response",

author = "Debu Tripathy and Aditya Bardia and Sellers, {William R.}",

note = "Funding Information: The project described was supported in part by award number P30CA014089 from the NCI (to D. Tripathy). A. Bardia is supported by the NIH (4K12CA087723-14). Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.",

year = "2017",

month = sep,

day = "15",

doi = "10.1158/1078-0432.CCR-17-1819",

language = "English (US)",

volume = "23",

pages = "5658",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

TY - JOUR

T1 - Mechanism of action and clinical impact of ribociclib — Response

AU - Tripathy, Debu

AU - Bardia, Aditya

AU - Sellers, William R.

N1 - Funding Information: The project described was supported in part by award number P30CA014089 from the NCI (to D. Tripathy). A. Bardia is supported by the NIH (4K12CA087723-14). Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.

PY - 2017/9/15

Y1 - 2017/9/15

UR - http://www.scopus.com/inward/record.url?scp=85029475739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029475739&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-17-1819

DO - 10.1158/1078-0432.CCR-17-1819

M3 - Letter

C2 - 28916619

AN - SCOPUS:85029475739

SN - 1078-0432

VL - 23

SP - 5658

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 18

ER -

Mechanism of action and clinical impact of ribociclib — Response

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this